146 related articles for article (PubMed ID: 6765335)
1. Activation of tumoricidal properties in macrophages by lymphokines encapsulated in liposomes.
Fidler IJ; Fogler WE
Lymphokine Res; 1982; 1(3):73-7. PubMed ID: 6765335
[No Abstract] [Full Text] [Related]
2. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste G; Kirsh R; Fogler WE; Fidler IJ
Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
[TBL] [Abstract][Full Text] [Related]
3. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
4. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
[TBL] [Abstract][Full Text] [Related]
5. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
6. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages.
Poste G; Kirsh R
Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267
[TBL] [Abstract][Full Text] [Related]
7. Liposome-encapsulated macrophage activation agents and active non-specific immunotherapy of neoplastic disease.
Poste G; Kirsh R
Prog Clin Biol Res; 1982; 102 pt A():309-19. PubMed ID: 7167443
[No Abstract] [Full Text] [Related]
8. Macrophage activation: synergism between hybridoma MAF and poly(I). Poly(C) delivered by liposomes.
Pidgeon C; Schreiber RD; Schultz RM
J Immunol; 1983 Jul; 131(1):311-4. PubMed ID: 6408176
[TBL] [Abstract][Full Text] [Related]
9. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
Fidler IJ; Schroit AJ
J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
[TBL] [Abstract][Full Text] [Related]
10. The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.
Poste G
Am J Pathol; 1979 Aug; 96(2):595-610. PubMed ID: 382866
[TBL] [Abstract][Full Text] [Related]
11. The generation of tumoricidal activity in macrophages for the treatment of established metastases.
Fidler IJ
Symp Fundam Cancer Res; 1983; 36():421-35. PubMed ID: 6382518
[No Abstract] [Full Text] [Related]
12. Lymphokines and bacteria, that induce tumoricidal activity, trigger a different secretory response in macrophages.
Keller R; Keist R; Frei K
Eur J Immunol; 1990 Mar; 20(3):695-8. PubMed ID: 2108046
[TBL] [Abstract][Full Text] [Related]
13. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
Sone S; Poste G; Fidler IJ
J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253
[TBL] [Abstract][Full Text] [Related]
14. Activating factors for nonspecific and antibody-dependent cytotoxicity by human and murine mononuclear phagocytes.
Ralph P
Lymphokine Res; 1984; 3(4):153-61. PubMed ID: 6208440
[No Abstract] [Full Text] [Related]
15. Production and utilization of human lymphokines containing macrophage-activating factor (MAF) activity.
Kleinerman ES; Fidler IJ
Lymphokine Res; 1983; 2(1):7-12. PubMed ID: 6381900
[No Abstract] [Full Text] [Related]
16. Activation of tumoricidal properties in murine macrophages by intravenous injection of muramyl dipeptide encapsulated within liposomes as a treatment for spontaneous metastasis.
Fidler IJ; Poste G
Prog Clin Biol Res; 1981; 75B():257-67. PubMed ID: 7323097
[No Abstract] [Full Text] [Related]
17. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
Fidler IJ; Raz A; Fogler WE; Kirsh R; Bugelski P; Poste G
Cancer Res; 1980 Dec; 40(12):4460-6. PubMed ID: 7002293
[TBL] [Abstract][Full Text] [Related]
18. Intracellular activation of human and rodent macrophages by human lymphokines encapsulated in liposomes.
Kleinerman ES; Fogler WE; Fidler IJ
J Leukoc Biol; 1985 May; 37(5):571-84. PubMed ID: 3920339
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
Sone S; Fidler IJ
J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
[TBL] [Abstract][Full Text] [Related]
20. Suppression of natural tumor resistance by tumor promoters.
Keller R; Keist R; Köppel P; Hecker E
Carcinog Compr Surv; 1982; 7():643-5. PubMed ID: 7039836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
